APLM – apollomics inc. - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apollomics Announces Presentation at the 2024 BIO International Convention
Apollomics Announces Private Placement Financing and Addition to Board of Directors
Apollomics, Inc. (NASDAQ: APLM) had its price target lowered by analysts at HC Wainwright from $5.00 to $2.00. They now have a "buy" rating on the stock.
Form SC 13G/A Apollomics Inc. Filed by: Maxpro Investment Co., Ltd
Form EFFECT Apollomics Inc.
Form 424B3 Apollomics Inc.
Form 6-K Apollomics Inc. For: May 24
Form 424B5 Apollomics Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.